Mehdi Hedayati is an expert in Endocrinology at Shahid Beheshti University of Medical Sciences (Iran). As of October 2026, ScienceLeadR ranks Mehdi Hedayati in the top 1% of experts worldwide for Thyroid Neoplasms, Endocrine Gland Neoplasms and Glucose Metabolism Disorders. Mehdi Hedayati has authored 676 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 1,682 (community average: 125). How the SLR is computed.

LeadR Profile

1 682 ScienceLeadR Reputation 1682
Network Map

Endocrinology

Subspecialties: Biochemistry - Genetics - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Mehdi Hedayati, PhD is a Professor of Biochemistry and Director of the Cellular and Molecular Endocrine Research Center at Shahid Beheshti University of Medical Sciences. He is currently a Visiting Scholar at Trent University, Ontario, Canada.

With more than two decades of research experience, Dr. Hedayati's work focuses on the biochemical, molecular, and genetic aspects of thyroid disorders, particularly thyroid cancer. His research integrates molecular endocrinology, biomarker discovery, and metabolomics to identify novel diagnostic and prognostic markers for thyroid diseases and to improve patient monitoring and follow-up strategies.

Dr. Hedayati is also an experienced laboratory methodologist with expertise in assay development, analytical validation, translational research, and omics-based approaches. He has authored more than 500 scientific publications, received over 14,000 citations, and has an H-index exceeding 55. His current research interests include metabolomics-driven precision diagnostics and systems-level approaches to endocrine diseases.

Organizations

Career arc: 2003 - 2026

Source: PubMed

Shahid Beheshti University of Medical Sciences

Publications Synthesis

Sources: PubMed, OpenAlex

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Early life stress caused glucose homeostasis impairment and anxiety-like behavior along with oxidative stress in adolescent male rat offspring: Protective effect of saffron extract.
PMID 42842729 — insulin, homeostasis, stress, physiological, oxidative stress, amygdala, pancreas, adolescent, catalase, stress, psychological, plasma
PLoS One20260
The Interplay Between Thyroid Cancer and Cardiovascular Disease: Shared Mechanisms, Treatment Implications, and Survivorship Perspectives.
PMID 42768160 — cancer survivors, heart diseases, heart, cardiovascular diseases, neoplasms, thyroid gland, atrial fibrillation, hormones, survivorship, thyroid neoplasms, therapeutics
Cardiovasc Toxicol20260
High Serum Monounsaturated Fatty Acids Levels May Increase Risk of Cardiovascular Disease: A Mendelian Randomization Study.
PMID 42764857 — hypertension, fatty acids, monounsaturated, serum, cardiovascular diseases, random allocation, fatty acids
Iran J Med Sci20260
A 25-year Experience in Quality Assurance: A Methodological Review of Laboratory Quality Control and Quality Assurance in the Tehran Lipid and Glucose Study (TLGS).
PMID 42763642 — research design, quality control, creatinine, longitudinal studies, laboratories, cholesterol, triglycerides
Int J Endocrinol Metab20260
Polyphenols intake and expression of insulin signaling genes in adipose tissue of obese adults: a cross-sectional study.
PMID 42675145 — flavanones, genes, cross-sectional studies, insulin, stilbenes, obesity, flavonoids, tissues, polyphenols, adipose tissue, gene expression, anthocyanins
Sci Rep20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 7
Phase 2/Phase 3 1

By status:

Completed 4
Unknown 3
Not yet recruiting 1

By type:

Interventional 8

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients
NCT06096558 — quality of life, starch, blood, melatonin, peritoneal dialysis, sleep, lipoproteins, c-reactive protein, cardiovascular diseases, blood pressure, dietary supplements, tablets, cholesterol, risk factors, lipoprotein(a)
N/ANot yet recruiting2023

LeadR Networks

Main global connection map